The FDA issues warning letters requiring the company to cease prohibited marketing claims, reformulate the product, or stop selling it entirely
Gorman, GS, Chinnery, PF, DiMauro, S, Hirano, M, Koga, Y, McFarland, R, Suomalainen, A, Thorburn, DR, Zeviani, M, Turnbull, DM 2016, Mitochondrial diseases, Nature Reviews Disease Primers , vol
Osteocalcin and serum insulin-like growth factor-1 as biochemical skeletal maturity indicators
PMID 11116185
The FDA's own career scientists have published documents outlining concerns that even if peptides are trendy, evidence to support loosening restrictions is still inadequate
Its much less potent than GLP-1s, but the muscle-sparing effect is important, as one-third of the weight lost on GLP-1s is muscle mass